Pharma Stocks
-
Is Pfizer Stock the Only Big Pharma Name I’d Buy and Hold Through Any Market Crash?
New products are already generating growth. Pfizer (PFE 0.73%) is the name behind one of the world’s top-selling products: the…
Read More » -
Lupin, Biocon, Torrent Pharma Show Technical Strength
The Technical Breakout Candidates The Indian pharmaceutical sector has demonstrated significant strength, outpacing the broader Nifty 50 index with a…
Read More » -
Strides Pharma Science Ltd Technical Momentum Shifts Amid…
Technical Trend Overview and Price Momentum Strides Pharma Science Ltd (NSE: 688428), a prominent player in the Pharmaceuticals & Biotechnology…
Read More » -
12 Health Care Stocks Moving In Thursday’s Intraday Session – Apimeds Pharmaceuticals (AMEX:APUS), Artelo Biosciences (NASDAQ:ARTL)
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 54.1% to $1.97 during Thursday’s regular session. The company’s market cap stands…
Read More » -
Eupraxia Pharma Prices $55 Mln Offering Of Shares And Warrants; Stock Down
(RTTNews) – Eupraxia Pharmaceuticals Inc. (EPRX) , a clinical-stage biotechnology company, announced the pricing of the public offering of 6.43…
Read More » -
Divis Labs, Lupin, Dr Reddy’s, Glenmark: Check fresh targets for Pharma stocks post Q3
Choice Institutional Equities believes that expansion in global market ex-US, biosimilars and peptides patents, CDMO and backward integration for margin…
Read More » -
Dr Reddy’s Labs shares in focus as pharma major inks $32 million deal; key details
Dr Reddy’s Laboratories shares are likely to be in focus on Thursday following an announcement that the pharma major has…
Read More » -
K.P. Energy, NATCO Pharma and 3 other stocks with 3 year profit CAGR up to 140% to keep an eye
Synopsis: These small-cap stocks have delivered robust 3-year profit CAGRs of up to 140%, accompanied by strong revenue growth, highlighting…
Read More » -
aTyr Pharma Insiders Added US$926.8k Of Stock To Their Holdings
In the last year, multiple insiders have substantially increased their holdings of aTyr Pharma, Inc. (NASDAQ:ATYR) stock, indicating that insiders’…
Read More » -
A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings
Botanix Pharmaceuticals (ASX:BOT) has drawn fresh attention after filing multiple follow on equity offerings totaling A$45 million. The company is…
Read More »